https://www.controlpointdx.com/home-subscribe daily 0.75 2021-07-15 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626376002243-XSNDPG8KJTMM7L68A56B/dark+blue+green.png Home Subscribe https://www.controlpointdx.com/paula-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1628542784046-I7ZJQTAVZA3PG1VU2717/paula+square.jpg Paula About - Paula Walker F ounder, CEO & Board Member Paula Walker, a veterinarian and entrepreneur, possesses over two decades of combined experience in regulatory and clinical areas. Her expertise encompasses the design, management, and monitoring of clinical trials, supporting domestic (FDA) and ex-US regulatory reviews in infectious disease, virology, and oncology women’s health, pharmaceutical, and molecular assays. Walker has made significant contributions to strategic product development plans, business plans, and has served as a clinical subject matter expert for various cross-functional development teams. Notably, she has facilitated several FDA clearances, ranging from moderately complex molecular infectious diseases and CLIA waiver applications, including LIAT (Roche’s first CLIA waived point-of-care molecular in-vitro diagnostic device) and Cepheid assays for Strep A and Flu. Additionally, she obtained FDA Emergency Use Authorization for two COVID-19 devices and FDA clearance for a sexually transmitted infections device, both for Visby Medical. https://www.controlpointdx.com/paul-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1628543514392-0ENM8A5SJKL4QIWVUPYM/paul+sq.jpg Paul About - Paul Hays Board Member President & CEO of Med-Pharmex, Inc., a developer, manufacturer, and distributor of veterinary drugs for companion animals and livestock located in Pomona, California. Mr. Hays has devoted his entire career, over 30 years, to the animal health industry. Prior to joining Med-Pharmex, Mr. Hays was President & CEO for Virbac’s North American business, leading the acquisition of SENTINEL® brand parasiticide, strengthening the commercial organization and leading the turnaround of their FDA production facilities. He has also served as Chief Commercial Officer of Vets Plus and Vice President of Global Diagnostics at Pfizer Animal Health (today, Zoetis) where he led their entry into veterinary diagnostics through the integration of Synbiotics Corporation into Pfizer’s global business. Hays was Synbiotics’ President & CEO for eight years, first as a public company, which he took private and finally planned and led the sale to Pfizer. Preceding those roles, Hays held progressive senior management roles with Boehringer Ingelheim Vetmedica including VP of Sales & Marketing where he founded both their equine and swine business units. The swine business unit grew rapidly under his leadership with the launch of the first PRRS and Ileitis vaccines and through the acquisitions of Fermenta Animal Health and NOBL Laboratories. Subsequently, he worked in Germany headquarters as Corporate VP of Marketing & Area Businesses, then returned to lead the US business as Executive Vice President of U.S. Business Operations. Earlier in his career, he was part of the US start-up team for CIBA Animal Health (later, Novartis) and began his career as sales representative for Coopers Animal Health. He earned a bachelor’s degree in animal science from the University of Missouri. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1628543514392-0ENM8A5SJKL4QIWVUPYM/paul+sq.jpg Paul About - Paul Hays Board Member President & CEO of Med-Pharmex, Inc., a developer, manufacturer, and distributor of veterinary drugs for companion animals and livestock located in Pomona, California. Mr. Hays has devoted his entire career, over 30 years, to the animal health industry. Prior to joining Med-Pharmex, Mr. Hays was President & CEO for Virbac’s North American business, leading the acquisition of SENTINEL® brand parasiticide, strengthening the commercial organization and leading the turnaround of their FDA production facilities. He has also served as Chief Commercial Officer of Vets Plus and Vice President of Global Diagnostics at Pfizer Animal Health (today, Zoetis) where he led their entry into veterinary diagnostics through the integration of Synbiotics Corporation into Pfizer’s global business. Hays was Synbiotics’ President & CEO for eight years, first as a public company, which he took private and finally planned and led the sale to Pfizer. Preceding those roles, Hays held progressive senior management roles with Boehringer Ingelheim Vetmedica including VP of Sales & Marketing where he founded both their equine and swine business units. The swine business unit grew rapidly under his leadership with the launch of the first PRRS and Ileitis vaccines and through the acquisitions of Fermenta Animal Health and NOBL Laboratories. Subsequently, he worked in Germany headquarters as Corporate VP of Marketing & Area Businesses, then returned to lead the US business as Executive Vice President of U.S. Business Operations. Earlier in his career, he was part of the US start-up team for CIBA Animal Health (later, Novartis) and began his career as sales representative for Coopers Animal Health. He earned a bachelor’s degree in animal science from the University of Missouri. https://www.controlpointdx.com/greg-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/707b49ab-fcdd-4e54-a75a-9223c6069605/Greg+cp+pic.jpeg Greg About - Greg Svanas Sr. Clinical Research Associate Greg Svanas grew up in the oil fields of west Texas before receiving Bachelor of Arts degrees in biology and chemistry from Austin College. He then received a Ph.D. in biochemistry from Purdue University studying the enzymology of ethanol metabolism. His post-doctoral work was at the University of Pittsburgh School of Medicine studying metabolic changes in the diseased livers recovered from liver transplant patients. Greg then began working in industrial biochemistry with a focus on novel commercial human diagnostic kits. He has worked in small and large companies to develop rapid qualitative and quantitative tests for targets ranging from food poisoning to infectious diseases (e.g., sexually transmitted diseases) to blood heart attack markers. The assay formats ranged from urine dipsticks to manual and instrumented configurations. He is an author on 15 peer-reviewed articles and also presented an Xtalks webinar on installing a CGMP quality system in the R&D department of a contract drug manufacturer. Greg currently lives with his wife about 15 miles north of Oklahoma City in Edmond, Oklahoma. He enjoys public speaking, and he has been a member of Toastmasters for more than 10 years. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/707b49ab-fcdd-4e54-a75a-9223c6069605/Greg+cp+pic.jpeg Greg About - Greg Svanas Sr. Scientist Greg Svanas grew up in the oil fields of west Texas before receiving Bachelor of Arts degrees in biology and chemistry from Austin College. He then received a Ph.D. in biochemistry from Purdue University studying the enzymology of ethanol metabolism. His post-doctoral work was at the University of Pittsburgh School of Medicine studying metabolic changes in the diseased livers recovered from liver transplant patients. Greg then began working in industrial biochemistry with a focus on novel commercial human diagnostic kits. He has worked in small and large companies to develop rapid qualitative and quantitative tests for targets ranging from food poisoning to infectious diseases (e.g., sexually transmitted diseases) to blood heart attack markers. The assay formats ranged from urine dipsticks to manual and instrumented configurations. He is an author on 15 peer-reviewed articles and also presented an Xtalks webinar on installing a CGMP quality system in the R&D department of a contract drug manufacturer. Greg currently lives with his wife about 15 miles north of Oklahoma City in Edmond, Oklahoma. He enjoys public speaking, and he has been a member of Toastmasters for more than 10 years. https://www.controlpointdx.com/david-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1627420567657-5B914P4ZQIEXSIJRQIS6/davidsquare.png David About - David Soorholtz Marketing Advisor Over 25 years of experience in custom global marketing research in the animal health /nutrition sector. He is the founder and president of VetSense LLC. David also founded MarketSense, Inc., a premier agricultural market research and consulting firm with a focus on the animal health sector. He co-authored:Critical Thinking for Marketers, Vol 1&II: Learn How to Think, not What to Think. He has also served in key roles at Kleffmann, Syntex, Diamond, and Boehringer Ingelheim. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1627420567657-5B914P4ZQIEXSIJRQIS6/davidsquare.png David About - David Soorholtz Marketing Advisor Over 25 years of experience in custom global marketing research in the animal health /nutrition sector. He is the founder and president of VetSense LLC. David also founded MarketSense, Inc., a premier agricultural market research and consulting firm with a focus on the animal health sector. He co-authored:Critical Thinking for Marketers, Vol 1&II: Learn How to Think, not What to Think. He has also served in key roles at Kleffmann, Syntex, Diamond, and Boehringer Ingelheim. https://www.controlpointdx.com/tony-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/130785e6-6268-4bc3-89c2-4a3cad69a0c8/Tony+w+Abby+2023.png Tony About - Tony Rumschlag, DVM Dr. Tony Rumschlag, of Rumschlag Veterinary Consulting, works with veterinary hospitals, related businesses, and investors to solidify and grow brands. He earned his Bachelor of Science and Doctor of Veterinary Medicine degrees from Purdue University before practicing veterinary medicine in Atlanta, Ga. After five years, he shifted his career focus, holding a variety of medical support and managerial roles at Hill’s Pet Nutrition, Merial (now Boehringer Ingelheim) and Elanco. For more than 15 years at Elanco, Dr. Rumschlag led the Pet Health Consulting Veterinarians team where he oversaw post-approval studies and supported the launch of new products to better manage disease conditions and improve the health of pets. He eventually joined the innovations team searching for new technologies to benefit animals. He has strong connections and relationships in many facets of veterinary medicine including state and national veterinary associations and veterinary colleges. Dr. Rumschlag has been invited to speak at several state and national veterinary conferences, as well as conferences in Southeast Asia. Dr. Rumschlag has provided leadership in various state and national veterinary organizations continuously since 1995, including the Indiana Veterinary Medical Association, Indiana Animal Health Foundation, American Veterinary Medical Association’s Committee for Veterinary Technician Education and Activities and the American Heartworm Society. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/130785e6-6268-4bc3-89c2-4a3cad69a0c8/Tony+w+Abby+2023.png Tony About - Tony Rumschlag, DVM Scientific Advisor Dr. Tony Rumschlag, of Rumschlag Veterinary Consulting, works with veterinary hospitals, related businesses, and investors to solidify and grow brands. He earned his Bachelor of Science and Doctor of Veterinary Medicine degrees from Purdue University before practicing veterinary medicine in Atlanta, Ga. After five years, he shifted his career focus, holding a variety of medical support and managerial roles at Hill’s Pet Nutrition, Merial (now Boehringer Ingelheim) and Elanco. For more than 15 years at Elanco, Dr. Rumschlag led the Pet Health Consulting Veterinarians team where he oversaw post-approval studies and supported the launch of new products to better manage disease conditions and improve the health of pets. He eventually joined the innovations team searching for new technologies to benefit animals. He has strong connections and relationships in many facets of veterinary medicine including state and national veterinary associations and veterinary colleges. Dr. Rumschlag has been invited to speak at several state and national veterinary conferences, as well as conferences in Southeast Asia. Dr. Rumschlag has provided leadership in various state and national veterinary organizations continuously since 1995, including the Indiana Veterinary Medical Association, Indiana Animal Health Foundation, American Veterinary Medical Association’s Committee for Veterinary Technician Education and Activities and the American Heartworm Society. https://www.controlpointdx.com/steve-cole-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/0219cb14-a4b5-45ca-b326-0a599cb9b05e/headshot%5B260059%5D.png Stephen about - Dr. Stephen Cole VMD, MS, DACVM Dr. Stephen Cole is currently an Assistant Professor of Clinical Microbiology and Director of the Clinical Infectious Disease Diagnostic Lab at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet). His primary research interests seek to understand and mitigate the spread of extensively drug-resistant bacteria in companion animals and to establish best educational practices in antimicrobial stewardship to promote proper use of critical drugs. A dedicated educator, Dr. Cole teaches microbiology across the basic science and clinical curricula and currently co-directs a novel course focused on evidenced-based, bench-to-bedside veterinary medicine. Dr. Cole’s primary clinical specialties include clinical bacteriology and mycology, antimicrobial therapy and selection, and infectious diseases. Dr. Cole is a Diplomate of the American College of Veterinary Microbiology (Bacteriology/Mycology, Immunology, Virology), the recipient of the Peggy Cotter Early Career Award from the American Society of Microbiology, several SAVMA teaching awards and has been named a One Health Scholar by the American Association of Veterinary Medical Colleges. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/0219cb14-a4b5-45ca-b326-0a599cb9b05e/headshot%5B260059%5D.png Stephen about - Dr. Stephen Cole VMD, MS, DACVM. Scientific Advisor Dr. Stephen Cole is currently an Assistant Professor of Clinical Microbiology and Director of the Clinical Infectious Disease Diagnostic Lab at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet). His primary research interests seek to understand and mitigate the spread of extensively drug-resistant bacteria in companion animals and to establish best educational practices in antimicrobial stewardship to promote proper use of critical drugs. A dedicated educator, Dr. Cole teaches microbiology across the basic science and clinical curricula and currently co-directs a novel course focused on evidenced-based, bench-to-bedside veterinary medicine. Dr. Cole’s primary clinical specialties include clinical bacteriology and mycology, antimicrobial therapy and selection, and infectious diseases. Dr. Cole is a Diplomate of the American College of Veterinary Microbiology (Bacteriology/Mycology, Immunology, Virology), the recipient of the Peggy Cotter Early Career Award from the American Society of Microbiology, several SAVMA teaching awards and has been named a One Health Scholar by the American Association of Veterinary Medical Colleges. https://www.controlpointdx.com/steve-about daily 0.75 2025-11-26 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/31fccbe0-ed48-4589-afa0-e2ab252efacd/Steve+Schram+photo.jpg Steve About - Steve Schram Experienced CEO/Sales and Marketing Executive with a demonstrated 38-year history of leading businesses in the pharmaceuticals and biologics industry. Skilled in go to market strategy and implementation of veterinary products for the North American market. Successful history in business development, acquisitions, and business exits. Strong strategic planning and business acumen to help existing and startup businesses achieve their business goals. Schram Consulting was formed in 2021 after a 38-year career with three animal health companies over his career. Norbrook Animal Health Steve was previously VP of Sales and Marketing for the America’s for Norbrook starting in 2018. During his tenure with Norbrook, he led seven new generic launches in the North American market. AgriLabs/Benchmark/VaxLiant Companies Steve was CEO of AgriLabs® for 23 years until 2017, when he led the exit strategy for the board selling all the companies to Huvepharma in 2017. After joining the company in 1995, he was instrumental in making significant investments in R&D to develop new generic pharmaceuticals and novel biological products. Also, securing licensing deals that included several domestic and international arrangements, leading to successful introductions of new products to the United States marketplace. In 2014, the company purchased a contract research company, Benchmark Biolabs and co-founded a vaccine adjuvant business VaxLiant. Syntex Animal Health Steve began his animal health career in 1983 as a territory manager. Over the next 12 years, Steve held several sales and marketing positions. In his last position as Business Unit Manager for Anthelmintics, he was part of the team that exited the business to Fort Dodge Animal Health in 1995. Steve earned an BS in animal science from Iowa State University in 1983. Since graduation, Steve has completed several manager programs including Columbia School of Marketing, Purdue University Business School, and 20 years in the Chief Executive Network. In addition, Steve has served on both non for profit and for-profit boards in the industry and community, including banking, manufacturing, business incubator, business schools and health care. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/31fccbe0-ed48-4589-afa0-e2ab252efacd/Steve+Schram+photo.jpg Steve About - Steve Schram Board Member Experienced CEO/Sales and Marketing Executive with a demonstrated 38-year history of leading businesses in the pharmaceuticals and biologics industry. Skilled in go to market strategy and implementation of veterinary products for the North American market. Successful history in business development, acquisitions, and business exits. Strong strategic planning and business acumen to help existing and startup businesses achieve their business goals. Schram Consulting was formed in 2021 after a 38-year career with three animal health companies over his career. Norbrook Animal Health Steve was previously VP of Sales and Marketing for the America’s for Norbrook starting in 2018. During his tenure with Norbrook, he led seven new generic launches in the North American market. AgriLabs/Benchmark/VaxLiant Companies Steve was CEO of AgriLabs® for 23 years until 2017, when he led the exit strategy for the board selling all the companies to Huvepharma in 2017. After joining the company in 1995, he was instrumental in making significant investments in R&D to develop new generic pharmaceuticals and novel biological products. Also, securing licensing deals that included several domestic and international arrangements, leading to successful introductions of new products to the United States marketplace. In 2014, the company purchased a contract research company, Benchmark Biolabs and co-founded a vaccine adjuvant business VaxLiant. Syntex Animal Health Steve began his animal health career in 1983 as a territory manager. Over the next 12 years, Steve held several sales and marketing positions. In his last position as Business Unit Manager for Anthelmintics, he was part of the team that exited the business to Fort Dodge Animal Health in 1995. Steve earned an BS in animal science from Iowa State University in 1983. Since graduation, Steve has completed several manager programs including Columbia School of Marketing, Purdue University Business School, and 20 years in the Chief Executive Network. In addition, Steve has served on both non for profit and for-profit boards in the industry and community, including banking, manufacturing, business incubator, business schools and health care. https://www.controlpointdx.com/contact daily 0.75 2025-11-27 https://www.controlpointdx.com/home daily 1.0 2026-02-17 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626455869930-B7ACLOEH7EH2UN6JHHD3/blueblock+2+darker+202.90.49.JPG Product https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618511387030-5LI1E5QMVTQ2RY9S00A4/20140228_Trade+151_0046+1.jpg Product https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618511440608-5BVMHVN4WR2I9YQV1WWR/Aro+Ha_0010+1.jpg Product https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618511467879-K5J9BYNACHJVDV3BNSFU/Aro+Ha_0387+1.jpg Product https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618511743693-J3A8OYH6X8C7RXNU5K0J/20140301_Trade+151_0124+1.jpg Product https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615675795-B3QKQMPRGN64IMCQYOO6/images.jpg Product - NSF SEED Fund (Copy) NSF SEED Fund https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615644975-93VUK7RK5VDBI569IHPN/images.png Product - Leap (Copy) Leap https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615657639-9AR89XQG82ECB7W3BY1H/637f9afebebb0a0742b99051_plug-and-play-logo-blue.451860baa333.png Product - Plug and Play (Copy) Plug and Play https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615536959-IP7NWFCY53HZ6KI6G7QW/petcareinnovationsummitlogo-1.png Product - Petcare Innovation Summit (Copy) Petcare Innovation Summit https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615571461-H91QF0IHA9S194WGHPNR/ks210723_animal_health_nutrition_and_technology_innovation_europe_logo_final.png Product - Animal Health, Nutrition & Technology Innovation Europe (Copy) Animal Health, Nutrition & Technology Innovation Europe https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615611503-QIJ8G1J233FD414V383E/kisacodigitalveterinarylogonew_2021.png Product - Digital Veterinary Summit (Copy) Digital Veterinary Summit https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748615490926-AM6UCJQAB2PBPBIDE13W/image-asset.jpeg Product - newchip (Copy) newchip https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626479699073-28K0TJJJ3ADDLSIPSUNZ/5min+vector.JPG Product - results within minutes Rapid testing will offer veterinarians fast results giving owners more time with their pets. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626479822238-5YU81MWR0WT30G2UMHX5/pathogen+vector.JPG Product - Single test for several pathogens Testing for multiple pathogens enables veterinarians to address specific conditions. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626479934453-DNXOITBTN0TUXZ82HX0Y/smart+phone+vector.JPG Product - Sharable Test results Using the QR code will allow users to view test results instantly on their ControlPoint mobile app. https://www.controlpointdx.com/team daily 0.75 2025-11-27 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626389844584-D7N36J26WUCMC5MBFQCI/paula+head+shot.png Team https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/38848951-1c4f-4022-b9dc-66f51e8a2558/Greg+cp+pic.jpeg Team https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626565253513-JML0VFT3T3DPBCLHAFUX/davids.png Team https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1626564587163-SNLP3H0D3KKTWQLTBC79/paul.png Team https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/09275ffa-d956-49e1-b5b7-78293d4045e2/Tony+w+Abby+2023.png Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1632886297930-DEPEEN3RE1QNZRN9E904/Steve+Schram+photo.jpg Team https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1e69b56f-f6b9-4e36-b786-2b12d0eb0454/headshot%5B260059%5D.png Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.controlpointdx.com/vision-mission-values daily 0.75 2026-01-08 https://www.controlpointdx.com/more-about-kennel-cough daily 0.75 2026-02-13 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1657834945363-8O3PCTVS0TPX8O71OCL4/AdobeStock_365165749+%5BConverted%5D.png More About Kennel Cough - Clinical Signs to observe in your dog The main clinical sign in dogs is coughing – a dry hacking cough or honking. It may be dry or productive, meaning it may be followed by a gag or swallowing. Some coughs may sound more like a reverse sneeze, a post-nasal drip, or a tickle in the throat. 5 Coughing may be worse with excitement or exercise. Other signs of kennel cough may include nasal discharge, retching, anorexia, depression, and fever. 1 Clinical signs are highly variable and difficult to predict, from mild illness to pneumonia. 4 The duration of clinical signs can be as short as 1 to 2 days or up to several weeks. 1 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1657835876471-ZR9UGHVRZR634KHDDD2E/AdobeStock_34432981.jpeg More About Kennel Cough - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1659457121853-ZGFJEWFQ7H8FPD86FOZ5/AdobeStock_211713743.jpeg More About Kennel Cough - Diagnosis If you suspect your dog may have kennel cough, contact your veterinarian and keep your dog away from other dogs. Diagnosing kennel cough will require a conversation with your veterinarian but may not require a veterinary visit if symptoms are mild. If a veterinary visit is recommended, it will likely include a physical examination and collection of the dog’s history, including a discussion of potential exposure from other dogs. A complete blood count, serum biochemistry and urinalysis may be performed.3 A bacterial culture obtained from nasal swabs, oropharyngeal swabs, or tracheal washes may also be required.1 The results of these tests may take several days (varies by capabilities in each veterinary office). Rapid diagnostics have led to faster test-to-result turnaround time, reduced follow-up loss, and enabled prompt case management. Kennel cough often shares similar clinical signs with other viral and/or bacterial illnesses, and a dog may harbor several co-infections. However, there is currently no rapid on-site testing with the ability to simultaneously detect multiple disease agents and results reporting for kennel cough. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1659457168036-94I5TUT8UKTZA6PTRAIA/AdobeStock_150680230.jpeg More About Kennel Cough - Treatment If your dog is exhibiting signs of kennel cough, contact your veterinarian immediately and keep them away from other dogs. In some cases, a visit to the veterinarian may not be necessary. Clinical signs in most dogs will resolve without treatment. A cough suppressant may be prescribed to provide relief to the dog and pet owner, especially since the cough can persist for weeks and may worsen during the night. Clinical signs worsen when the dog lays down and the lungs and nasal cavities are resting on one side for a longer time, worsening the clinical signs. Over-the-counter antitussive medications may be effective for dogs with mild clinical signs. Dogs with clinical signs persisting beyond one week should likely see their veterinarians and receive treatment with antimicrobials.3 Quarantining infected dogs should continue 14 days after clinical signs have been resolved, as this is generally how long it takes for a dog to clear the infection and no longer be contagious.6 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1659494273783-SISIUB9R6J6LS5W0XKNX/unsplash-image-KvKop_a_EXw.jpg More About Kennel Cough https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1659493914979-1SS3YECZSI7DX2DX0Z4K/unsplash-image-PcKhVNNyEio.jpg More About Kennel Cough - Veterinary Visit My veterinarian offered to take a blood sample and prescribed antibiotics as an initial treatment. The blood sample was going to total over $300. No additional testing was offered to diagnose kennel cough. Blood test results would be returned in about a week. I opted not to proceed with the blood sample since the veterinarian’s instinct indicated kennel cough was the most likely diagnosis. The antibiotics were more than $30/day for a 10-day treatment and should be given twice a day. In addition, the veterinarian prescribed an antinausea medication and cough suppressant. Through my own research online, I learned cough medicine and honey are potential solutions. The honey seemed to help. https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1659493867802-3A3P5Q6H90B5RZ3S21CK/unsplash-image-dw7paFI1jnM.jpg More About Kennel Cough - Very Slow Improvement Vino was better during the day – albeit a bit tired -- but the nights were awful. He continued to cough for the next two weeks, especially during the night. Three weeks after I returned from traveling for work, Vino was still coughing, but slowly improving. He has now recovered and is back to being himself. https://www.controlpointdx.com/services daily 0.75 2026-02-21 https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1627413498350-EUT97ZWJQ2HKFNDQUCSP/CP_Device+vertical+blue+line_07.27.21_v1.jpg The Test We are developing the first ever single testing method for multiple pathogens with a potential role in kennel cough. - Product and design under development- https://images.squarespace-cdn.com/content/v1/60f086fb7395013e4544b742/1748440659635-CIVFBMLPQVJIJBF9XAVN/How%2Bit%2Bworks.png The Test https://www.controlpointdx.com/references daily 0.75 2026-02-13